nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—MAOA—locus ceruleus—narcolepsy	0.105	0.458	CbGeAlD
Phenylephrine—ADRA1D—forebrain—narcolepsy	0.0228	0.0997	CbGeAlD
Phenylephrine—ADRA1D—Amine ligand-binding receptors—HRH3—narcolepsy	0.0167	0.0218	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Other—P2RY11—narcolepsy	0.0156	0.0204	CbGpPWpGaD
Phenylephrine—ADRA1B—Amine ligand-binding receptors—HRH3—narcolepsy	0.0139	0.0181	CbGpPWpGaD
Phenylephrine—ADRA1A—brainstem—narcolepsy	0.0136	0.0594	CbGeAlD
Phenylephrine—MAOA—brainstem—narcolepsy	0.0135	0.0588	CbGeAlD
Phenylephrine—ADRA1A—forebrain—narcolepsy	0.0131	0.0573	CbGeAlD
Phenylephrine—MAOA—forebrain—narcolepsy	0.013	0.0568	CbGeAlD
Phenylephrine—ADRA1B—AMPK Signaling—CPT1B—narcolepsy	0.0129	0.0169	CbGpPWpGaD
Phenylephrine—ADRA1A—Amine ligand-binding receptors—HRH3—narcolepsy	0.0123	0.0161	CbGpPWpGaD
Phenylephrine—ADRA1A—AMPK Signaling—CPT1B—narcolepsy	0.0115	0.015	CbGpPWpGaD
Phenylephrine—ADRA1D—Monoamine GPCRs—HTR2A—narcolepsy	0.00991	0.0129	CbGpPWpGaD
Phenylephrine—ADRA1B—brain—narcolepsy	0.00969	0.0423	CbGeAlD
Phenylephrine—ADRA1D—brain—narcolepsy	0.00948	0.0414	CbGeAlD
Phenylephrine—MAOA—medulla oblongata—narcolepsy	0.0094	0.041	CbGeAlD
Phenylephrine—ADRA1D—G alpha (q) signalling events—HCRTR2—narcolepsy	0.00909	0.0119	CbGpPWpGaD
Phenylephrine—ADRA1D—G alpha (q) signalling events—HCRTR1—narcolepsy	0.00909	0.0119	CbGpPWpGaD
Phenylephrine—ADRA1D—G alpha (q) signalling events—P2RY11—narcolepsy	0.00878	0.0115	CbGpPWpGaD
Phenylephrine—MAOA—midbrain—narcolepsy	0.00859	0.0375	CbGeAlD
Phenylephrine—ADRA1D—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00833	0.0109	CbGpPWpGaD
Phenylephrine—ADRA1B—Monoamine GPCRs—HTR2A—narcolepsy	0.00822	0.0107	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00813	0.0106	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00813	0.0106	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00785	0.0102	CbGpPWpGaD
Phenylephrine—ADRA1B—G alpha (q) signalling events—HCRTR2—narcolepsy	0.00755	0.00984	CbGpPWpGaD
Phenylephrine—ADRA1B—G alpha (q) signalling events—HCRTR1—narcolepsy	0.00755	0.00984	CbGpPWpGaD
Phenylephrine—ADRA1D—G alpha (q) signalling events—HCRT—narcolepsy	0.00747	0.00974	CbGpPWpGaD
Phenylephrine—ADRA1A—Monoamine GPCRs—HTR2A—narcolepsy	0.0073	0.00953	CbGpPWpGaD
Phenylephrine—ADRA1B—G alpha (q) signalling events—P2RY11—narcolepsy	0.00729	0.00951	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00703	0.00917	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00703	0.00917	CbGpPWpGaD
Phenylephrine—ADRA1B—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00691	0.00902	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00679	0.00885	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00675	0.0088	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00675	0.0088	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0067	0.00874	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0067	0.00874	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00668	0.00871	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00652	0.0085	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—P2RY11—narcolepsy	0.00647	0.00845	CbGpPWpGaD
Phenylephrine—ADRA1B—G alpha (q) signalling events—HCRT—narcolepsy	0.0062	0.00808	CbGpPWpGaD
Phenylephrine—ADRA1A—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00614	0.00801	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00602	0.00786	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00602	0.00786	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.006	0.00782	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.006	0.00782	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00583	0.00761	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00583	0.00761	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00582	0.00759	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.00579	0.00755	CbGpPWpGaD
Phenylephrine—ADRA1D—G alpha (q) signalling events—TRH—narcolepsy	0.00566	0.00738	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00563	0.00735	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00554	0.00723	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—HCRT—narcolepsy	0.0055	0.00718	CbGpPWpGaD
Phenylephrine—ADRA1A—brain—narcolepsy	0.00544	0.0238	CbGeAlD
Phenylephrine—MAOA—brain—narcolepsy	0.0054	0.0236	CbGeAlD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00518	0.00676	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00518	0.00676	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00506	0.0066	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.005	0.00653	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.005	0.00652	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.005	0.00652	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00495	0.00645	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00492	0.00642	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00487	0.00636	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00483	0.0063	CbGpPWpGaD
Phenylephrine—ADRA1B—G alpha (q) signalling events—TRH—narcolepsy	0.0047	0.00613	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—HCRTR2—narcolepsy	0.00459	0.00598	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—HCRTR1—narcolepsy	0.00459	0.00598	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00444	0.00579	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00444	0.00579	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—P2RY11—narcolepsy	0.00443	0.00578	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00441	0.00575	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Other—HTR2A—narcolepsy	0.0044	0.00574	CbGpPWpGaD
Phenylephrine—Epinephrine—TNF—narcolepsy	0.00434	1	CrCbGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00429	0.00559	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.0042	0.00548	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—TRH—narcolepsy	0.00417	0.00544	CbGpPWpGaD
Phenylephrine—ADRA1D—G alpha (q) signalling events—TAC1—narcolepsy	0.00411	0.00536	CbGpPWpGaD
Phenylephrine—ADRA1D—G alpha (q) signalling events—NPS—narcolepsy	0.00411	0.00536	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0041	0.00535	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00384	0.005	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—HCRTR2—narcolepsy	0.00381	0.00496	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—HCRTR1—narcolepsy	0.00381	0.00496	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—HCRT—narcolepsy	0.00377	0.00491	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00375	0.00489	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00373	0.00487	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00368	0.0048	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00368	0.0048	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—P2RY11—narcolepsy	0.00368	0.00479	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00366	0.00477	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00365	0.00476	CbGpPWpGaD
Phenylephrine—ADRA1B—G alpha (q) signalling events—TAC1—narcolepsy	0.00341	0.00445	CbGpPWpGaD
Phenylephrine—ADRA1B—G alpha (q) signalling events—NPS—narcolepsy	0.00341	0.00445	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—HCRTR1—narcolepsy	0.00338	0.00441	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—HCRTR2—narcolepsy	0.00338	0.00441	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—PENK—narcolepsy	0.00336	0.00438	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00329	0.00429	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—P2RY11—narcolepsy	0.00327	0.00426	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00325	0.00424	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00318	0.00415	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—HCRT—narcolepsy	0.00313	0.00408	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00311	0.00406	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00305	0.00398	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00305	0.00398	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—TAC1—narcolepsy	0.00303	0.00395	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—NPS—narcolepsy	0.00303	0.00395	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00293	0.00382	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—TRH—narcolepsy	0.00285	0.00372	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00283	0.00369	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—PENK—narcolepsy	0.00279	0.00363	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—HCRT—narcolepsy	0.00278	0.00362	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00276	0.0036	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00273	0.00356	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00272	0.00355	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00272	0.00355	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00271	0.00354	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00271	0.00354	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—HCRTR2—narcolepsy	0.00259	0.00338	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—HCRTR1—narcolepsy	0.00259	0.00338	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—P2RY11—narcolepsy	0.0025	0.00326	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—HRH3—narcolepsy	0.0025	0.00326	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—PENK—narcolepsy	0.00247	0.00323	CbGpPWpGaD
Phenylephrine—ADRA1D—G alpha (q) signalling events—HTR2A—narcolepsy	0.00247	0.00323	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00242	0.00316	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—TRH—narcolepsy	0.00237	0.00309	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HCRTR1—narcolepsy	0.00235	0.00307	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HCRTR2—narcolepsy	0.00235	0.00307	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—P2RY11—narcolepsy	0.00227	0.00296	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00226	0.00295	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00226	0.00295	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00221	0.00289	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—HCRTR1—narcolepsy	0.00215	0.00281	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—HCRTR2—narcolepsy	0.00215	0.00281	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—HCRT—narcolepsy	0.00213	0.00278	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—TRH—narcolepsy	0.0021	0.00274	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—P2RY11—narcolepsy	0.00208	0.00271	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—HRH3—narcolepsy	0.00208	0.00271	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—TAC1—narcolepsy	0.00207	0.0027	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—NPS—narcolepsy	0.00207	0.0027	CbGpPWpGaD
Phenylephrine—ADRA1B—G alpha (q) signalling events—HTR2A—narcolepsy	0.00205	0.00268	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00201	0.00262	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00201	0.00262	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HCRTR2—narcolepsy	0.00195	0.00255	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HCRTR1—narcolepsy	0.00195	0.00255	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CHKB—narcolepsy	0.00194	0.00253	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HCRT—narcolepsy	0.00193	0.00252	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00191	0.00249	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00191	0.00249	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00191	0.00249	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—PENK—narcolepsy	0.0019	0.00247	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—P2RY11—narcolepsy	0.00189	0.00246	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—P2RY11—narcolepsy	0.00185	0.00241	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—HRH3—narcolepsy	0.00184	0.00241	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00184	0.0024	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—HTR2A—narcolepsy	0.00182	0.00238	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—HCRT—narcolepsy	0.00177	0.0023	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HCRTR1—narcolepsy	0.00173	0.00226	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HCRTR2—narcolepsy	0.00173	0.00226	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—PENK—narcolepsy	0.00172	0.00225	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—NPS—narcolepsy	0.00172	0.00225	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—TAC1—narcolepsy	0.00172	0.00225	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—P2RY11—narcolepsy	0.00168	0.00219	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00164	0.00214	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00163	0.00213	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—TRH—narcolepsy	0.00161	0.0021	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HCRT—narcolepsy	0.0016	0.00209	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.0016	0.00209	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00159	0.00207	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PENK—narcolepsy	0.00157	0.00205	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—HCRT—narcolepsy	0.00157	0.00205	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—NPS—narcolepsy	0.00153	0.00199	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—TAC1—narcolepsy	0.00153	0.00199	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—TRH—narcolepsy	0.00146	0.00191	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PENK—narcolepsy	0.00143	0.00186	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HCRT—narcolepsy	0.00142	0.00186	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—HRH3—narcolepsy	0.00141	0.00184	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00141	0.00184	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PENK—narcolepsy	0.0014	0.00182	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HCRTR2—narcolepsy	0.00139	0.00181	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HCRTR1—narcolepsy	0.00139	0.00181	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00136	0.00177	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—P2RY11—narcolepsy	0.00134	0.00175	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—TRH—narcolepsy	0.00134	0.00175	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CPT1B—narcolepsy	0.00132	0.00172	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HRH3—narcolepsy	0.00128	0.00168	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PENK—narcolepsy	0.00127	0.00166	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—TNF—narcolepsy	0.00126	0.00164	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—HTR2A—narcolepsy	0.00125	0.00163	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.00124	0.00161	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.00124	0.00161	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—TRH—narcolepsy	0.00122	0.00159	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00121	0.00158	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—TRH—narcolepsy	0.00119	0.00155	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—HRH3—narcolepsy	0.00117	0.00153	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—NPS—narcolepsy	0.00117	0.00153	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—TAC1—narcolepsy	0.00117	0.00153	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HCRTR2—narcolepsy	0.00115	0.00151	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HCRTR1—narcolepsy	0.00115	0.00151	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HCRT—narcolepsy	0.00114	0.00149	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—P2RY11—narcolepsy	0.00111	0.00145	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00109	0.00142	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—TRH—narcolepsy	0.00108	0.00141	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HRH3—narcolepsy	0.00107	0.00139	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—TAC1—narcolepsy	0.00106	0.00139	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—NPS—narcolepsy	0.00106	0.00139	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—HRH3—narcolepsy	0.00104	0.00136	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—HTR2A—narcolepsy	0.00104	0.00135	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HCRTR1—narcolepsy	0.00102	0.00134	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HCRTR2—narcolepsy	0.00102	0.00134	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PENK—narcolepsy	0.00102	0.00133	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—P2RY11—narcolepsy	0.00099	0.00129	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—TAC1—narcolepsy	0.000973	0.00127	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—NPS—narcolepsy	0.000973	0.00127	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HCRT—narcolepsy	0.000948	0.00124	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HRH3—narcolepsy	0.000947	0.00124	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—HTR2A—narcolepsy	0.00092	0.0012	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—TAC1—narcolepsy	0.000883	0.00115	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—NPS—narcolepsy	0.000883	0.00115	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TRH—narcolepsy	0.000865	0.00113	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—TAC1—narcolepsy	0.000864	0.00113	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—NPS—narcolepsy	0.000864	0.00113	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PENK—narcolepsy	0.000845	0.0011	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HCRT—narcolepsy	0.000842	0.0011	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—NPS—narcolepsy	0.000785	0.00102	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—TAC1—narcolepsy	0.000785	0.00102	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HRH3—narcolepsy	0.000759	0.00099	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PENK—narcolepsy	0.00075	0.000979	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TRH—narcolepsy	0.000718	0.000937	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CHKB—narcolepsy	0.000714	0.000931	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—HTR2A—narcolepsy	0.000705	0.00092	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HTR2A—narcolepsy	0.00064	0.000835	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TRH—narcolepsy	0.000638	0.000832	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HRH3—narcolepsy	0.00063	0.000821	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TAC1—narcolepsy	0.000629	0.00082	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NPS—narcolepsy	0.000629	0.00082	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—HTR2A—narcolepsy	0.000585	0.000763	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HRH3—narcolepsy	0.000559	0.00073	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HTR2A—narcolepsy	0.000531	0.000693	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TAC1—narcolepsy	0.000522	0.000681	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NPS—narcolepsy	0.000522	0.000681	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—HTR2A—narcolepsy	0.00052	0.000678	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CPT1B—narcolepsy	0.000485	0.000633	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HTR2A—narcolepsy	0.000472	0.000616	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TAC1—narcolepsy	0.000463	0.000605	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NPS—narcolepsy	0.000463	0.000605	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HTR2A—narcolepsy	0.000378	0.000493	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HTR2A—narcolepsy	0.000314	0.000409	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HTR2A—narcolepsy	0.000279	0.000364	CbGpPWpGaD
